Analytical validation of the CellMax platform for early detection of cancer by enumeration of rare circulating tumor cells

The CellMax (CMx®) platform was developed to enrich for epithelial circulating tumor cells (CTCs) in the whole blood. This report provides assay performance data, including accuracy, linearity, limit of blank, limit of detection (LOD), specificity, and precision of enumeration of cancer cell line ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Pratyush, Gulzar, Zulfiqar, Hsieh, Ben, Lim, Austin, Watson, Drew, Mei, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939390/
https://www.ncbi.nlm.nih.gov/pubmed/31921364
http://dx.doi.org/10.1177/1849454419899214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939390/
https://www.ncbi.nlm.nih.gov/pubmed/31921364
http://dx.doi.org/10.1177/1849454419899214

Ejemplares similares